X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (198) 198
male (106) 106
female (103) 103
middle aged (83) 83
adult (77) 77
aged (74) 74
hematology (62) 62
in situ hybridization, fluorescence (58) 58
karyotyping (58) 58
oncology (56) 56
chromosome aberrations (54) 54
aged, 80 and over (44) 44
prognosis (39) 39
genetics & heredity (38) 38
cytogenetics (35) 35
translocation, genetic (32) 32
in-situ hybridization (29) 29
adolescent (25) 25
chromosome deletion (25) 25
fish (23) 23
chromosome disorders (22) 22
myelodysplastic syndromes - genetics (20) 20
chromosome banding (19) 19
index medicus (19) 19
leukemia (18) 18
child (17) 17
in situ hybridization, fluorescence - methods (17) 17
medicine, general & internal (17) 17
research (17) 17
diagnosis (16) 16
dna probes (16) 16
pathology (16) 16
survival analysis (16) 16
therapy (16) 16
treatment outcome (16) 16
abnormalities (15) 15
gene (15) 15
leukemia, lymphocytic, chronic, b-cell - genetics (15) 15
leukemia, myelogenous, chronic, bcr-abl positive - genetics (14) 14
metaphase (14) 14
bone marrow - pathology (13) 13
leukemia - genetics (13) 13
leukemia, myeloid - genetics (13) 13
acute disease (12) 12
antineoplastic combined chemotherapy protocols - therapeutic use (12) 12
cells (12) 12
expression (12) 12
interphase (12) 12
multiple myeloma - genetics (12) 12
multiple-myeloma (12) 12
myeloproliferative disorders - genetics (12) 12
primary myelofibrosis - genetics (12) 12
prospective studies (12) 12
survival (12) 12
aneuploidy (11) 11
antineoplastic agents - therapeutic use (11) 11
article (11) 11
cancer (11) 11
chromosomes (11) 11
chronic myelogenous leukemia (11) 11
chronic myeloid-leukemia (11) 11
phenotype (11) 11
philadelphia chromosome (11) 11
chromosome aberrations - genetics (10) 10
cytogenetic analysis (10) 10
disease-free survival (10) 10
genetic aspects (10) 10
hematology, oncology and palliative medicine (10) 10
immunoglobulin heavy chains - genetics (10) 10
myelodysplastic syndromes (10) 10
retrospective studies (10) 10
trisomy (10) 10
abnormalities, multiple - genetics (9) 9
acute myeloid-leukemia (9) 9
child, preschool (9) 9
chromosome (9) 9
chronic lymphocytic leukemia (9) 9
classification (9) 9
cohort studies (9) 9
disease progression (9) 9
fusion (9) 9
remission induction (9) 9
sensitivity and specificity (9) 9
survival rate (9) 9
acute myelogenous leukemia (8) 8
analysis (8) 8
bone-marrow (8) 8
chromosomes, human, pair 9 (8) 8
follow-up studies (8) 8
infant, newborn (8) 8
insitu hybridization (8) 8
interphase - genetics (8) 8
karyotype (8) 8
lymphoma - genetics (8) 8
medicine, research & experimental (8) 8
myelodysplastic syndrome (8) 8
polymerase chain reaction (8) 8
quality control (8) 8
risk factors (8) 8
translocation, genetic - genetics (8) 8
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (2) 2
Pontifical Inst. Mediaeval Studies - Library use only (1) 1
Pontifical Inst. Mediaeval Studies - Reference (1) 1
Robarts - Reference (1) 1
Trinity College (John W Graham) - Reference (1) 1
UTL at Downsview - May be requested (1) 1
UofT at Scarborough - May be requested in 6-10 wks (1) 1
Victoria University CRRS - Library use only (1) 1
Victoria University E.J. Pratt - Reference (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 09/2009, Volume 361, Issue 13, pp. 1249 - 1259
Patients with AML who were between 17 and 60 years of age were randomly assigned to receive induction therapy with the standard dose of daunorubicin or twice... 
CYTOSINE-ARABINOSIDE | MEDICINE, GENERAL & INTERNAL | ONCOLOGY-GROUP | INDUCTION CHEMOTHERAPY | ACUTE NONLYMPHOCYTIC LEUKEMIA | ACUTE MYELOGENOUS LEUKEMIA | ACUTE MYELOCYTIC-LEUKEMIA | GROUP-B | DAUNORUBICIN | REMISSION INDUCTION | UNTREATED ADULT PATIENTS | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Age Factors | Humans | Middle Aged | Antibiotics, Antineoplastic - adverse effects | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Leukemia, Myelomonocytic, Acute - drug therapy | Stem Cell Transplantation | Young Adult | fms-Like Tyrosine Kinase 3 - genetics | Leukemia, Myelomonocytic, Acute - therapy | Adult | Female | Remission Induction - methods | Daunorubicin - administration & dosage | Leukemia, Myelomonocytic, Acute - genetics | Histone-Lysine N-Methyltransferase | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | Combined Modality Therapy | Cytarabine - administration & dosage | Daunorubicin - adverse effects | Antibiotics, Antineoplastic - administration & dosage | Myeloid-Lymphoid Leukemia Protein - genetics | Adolescent | Infusions, Intravenous | Mutation | Leukemia, Myelomonocytic, Acute - mortality | Anthracyclines | Usage | Daunorubicin | Young adults | Health aspects | Bone marrow | Chemotherapy | Consolidation | Kinases | Index Medicus | Abridged Index Medicus
Journal Article
Blood, ISSN 0006-4971, 11/2011, Volume 118, Issue 21, pp. 3619 - 3619
Abstract Abstract 3619 Extramedullary (EM) acute myeloid leukemia (AML) is generally associated with a poor prognosis. We evaluated the baseline... 
Journal Article
Blood, ISSN 0006-4971, 04/2007, Volume 109, Issue 8, pp. 3189 - 3197
Journal Article
Journal Article
Blood, ISSN 0006-4971, 01/2007, Volume 109, Issue 2, pp. 405 - 411
Journal Article
Blood, ISSN 0006-4971, 11/2009, Volume 114, Issue 22, pp. 3405 - 3405
Abstract Abstract 3405 Poster Board III-293 Background: Autologous hematopoietic cell transplantation (AutoHCT) as consolidation has been an alternative to... 
Journal Article
American Journal of Surgical Pathology, ISSN 0147-5185, 12/2006, Volume 30, Issue 12, pp. 1546 - 1553
Journal Article